• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中的差异:肉瘤为例——寻求全球性问题的解决方案。

Disparities in Cancer Care: The Example of Sarcoma-In Search of Solutions for a Global Issue.

机构信息

McGill University Health Centre, Montreal, Quebec, Canada.

Cook Children's Medical Center, Fort Worth, TX.

出版信息

Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-7. doi: 10.1200/EDBK_320463.

DOI:10.1200/EDBK_320463
PMID:33770458
Abstract

Disparities in health care have an adverse effect on the outcome of disadvantaged patients with cancer. Patients may be at a disadvantage because of geographic isolation; insurance status; or racial, ethnic, or other factors. In this article, we examine how disparities affect the care of patients with sarcoma in the United States, Canada, and the Asia-Pacific region. Because of the rarity of sarcomas and their challenging diagnosis and complex treatment patterns, some professional or national guidelines stipulate that patients with sarcoma should be treated at centers of expertise by multidisciplinary teams. This recommendation, based on published evidence, is not always applicable because of various sociopolitical or patient-related factors. We are proposing solutions to overcome these obstacles in a practical and patient-centered way while acknowledging that disparities exist among countries as well as within any country.

摘要

医疗保健方面的差异对处于不利地位的癌症患者的治疗结果有不利影响。患者可能处于不利地位,原因包括地理位置偏远、保险状况,或种族、民族或其他因素。本文探讨了差异如何影响美国、加拿大和亚太地区肉瘤患者的治疗。由于肉瘤罕见,且其诊断和复杂的治疗模式极具挑战性,一些专业或国家指南规定肉瘤患者应在多学科团队的专业中心接受治疗。这一建议基于已发表的证据,但由于各种社会政治或与患者相关的因素,并不总是适用。我们正在提出切实可行的以患者为中心的解决方案来克服这些障碍,同时承认国家之间以及任何国家内部都存在差异。

相似文献

1
Disparities in Cancer Care: The Example of Sarcoma-In Search of Solutions for a Global Issue.癌症治疗中的差异:肉瘤为例——寻求全球性问题的解决方案。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-7. doi: 10.1200/EDBK_320463.
2
Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines.亚太地区肉瘤的治疗管理:资源分层指南。
Lancet Oncol. 2013 Nov;14(12):e562-70. doi: 10.1016/S1470-2045(13)70475-3.
3
Racial and ethnic disparities in medical and dental health, access to care, and use of services in US children.美国儿童在医疗和口腔健康、医疗服务可及性以及服务利用方面的种族和族裔差异。
Pediatrics. 2008 Feb;121(2):e286-98. doi: 10.1542/peds.2007-1243. Epub 2008 Jan 14.
4
Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas.保险对患有骨肉瘤和软组织肉瘤的儿童、青少年和年轻成年人的生存有影响。
Cancer Med. 2020 Feb;9(3):951-958. doi: 10.1002/cam4.2739. Epub 2019 Dec 15.
5
Racial and Ethnic Disparities in the Quality of Health Care.卫生保健质量中的种族和民族差异。
Annu Rev Public Health. 2016;37:375-94. doi: 10.1146/annurev-publhealth-032315-021439. Epub 2016 Jan 18.
6
Racial and Ethnic Disparities in Radiology: A Call to Action.放射学中的种族和民族差异:行动呼吁。
J Am Coll Radiol. 2019 Apr;16(4 Pt B):547-553. doi: 10.1016/j.jacr.2018.12.024.
7
Many Shades of Disparities in Myeloma Care.骨髓瘤治疗中差异的多种表现形式
Am Soc Clin Oncol Educ Book. 2019 Jan;39:519-529. doi: 10.1200/EDBK_238551. Epub 2019 May 17.
8
Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening.解释医师推荐结直肠癌筛查率方面的种族/民族差异的因素。
Am J Public Health. 2013 Jul;103(7):e91-9. doi: 10.2105/AJPH.2012.301034. Epub 2013 May 16.
9
The Centers for Medicare and Medicaid Services (CMS) COVID-19 Brief: Unsettling Racial and Ethnic Health Disparities.医疗保险和医疗补助服务中心(CMS)关于 COVID-19 的简报:令人不安的种族和族裔健康差异。
J Am Board Fam Med. 2021 Feb;34(Suppl):S13-S15. doi: 10.3122/jabfm.2021.S1.200450.
10
Engagement of health plans and employers in addressing racial and ethnic disparities in health care.让健康计划和雇主参与解决医疗保健中的种族和族裔差异问题。
Med Care Res Rev. 2009 Apr;66(2):219-31. doi: 10.1177/1077558708328816. Epub 2008 Dec 29.

引用本文的文献

1
Surgical Management of Retroperitoneal Liposarcoma: Opportunities for Multimodality Treatment, Including Systemic Therapy.腹膜后脂肪肉瘤的外科治疗:多模式治疗的机会,包括全身治疗。
Cancer Med. 2025 Aug;14(15):e71129. doi: 10.1002/cam4.71129.
2
Diagnostic Delay in Soft Tissue Sarcomas: A Review.软组织肉瘤的诊断延迟:综述
Cancers (Basel). 2025 May 31;17(11):1861. doi: 10.3390/cancers17111861.
3
Musculoskeletal Tumor Care Disparities Prior to Initiation of Treatment Among Newly Diagnosed Adult Patients.新诊断成年患者在开始治疗前的肌肉骨骼肿瘤护理差异
Cancers (Basel). 2025 Apr 30;17(9):1519. doi: 10.3390/cancers17091519.
4
ASO Author Reflections: Removing the Element of Surprise: Reducing Unplanned Excisions to Enhance Dermatofibrosarcoma Protuberans Outcomes.美国皮肤外科学会作者反思:消除意外因素:减少计划外切除以改善隆突性皮肤纤维肉瘤的治疗效果。
Ann Surg Oncol. 2025 Jul;32(7):5367-5368. doi: 10.1245/s10434-025-17177-0. Epub 2025 Mar 22.
5
Examining the Impact of Biopsy Technique on Clinical and Pathologic Outcomes in Dermatofibrosarcoma Protuberans: An International, Multi-Institutional Study.研究活检技术对隆突性皮肤纤维肉瘤临床和病理结果的影响:一项国际多机构研究
Ann Surg Oncol. 2025 May;32(5):3752-3762. doi: 10.1245/s10434-025-17011-7. Epub 2025 Feb 27.
6
Enhancing rare cancer care in developing countries through patient advocacy: insights from the Desmoid Tumor Brazilian Association.通过患者宣传增强发展中国家的罕见癌症护理:来自巴西硬纤维瘤肿瘤协会的见解。
Ther Adv Med Oncol. 2025 Jan 9;17:17588359241309827. doi: 10.1177/17588359241309827. eCollection 2025.
7
Barriers to care for musculoskeletal sarcoma patients: a public health perspective.肌肉骨骼肉瘤患者护理障碍:公共卫生视角。
Front Public Health. 2024 Aug 21;12:1399471. doi: 10.3389/fpubh.2024.1399471. eCollection 2024.
8
What Is a Sarcoma 'Specialist Center'? Multidisciplinary Research Finds an Answer.什么是肉瘤“专科中心”?多学科研究给出答案。
Cancers (Basel). 2024 May 13;16(10):1857. doi: 10.3390/cancers16101857.
9
Epidemiology and survival factors for sarcoma patients in minority populations: a SEER-retrospective study.少数族裔肉瘤患者的流行病学及生存因素:一项监测、流行病学和最终结果(SEER)回顾性研究
Rep Pract Oncol Radiother. 2023 Jul 25;28(3):370-378. doi: 10.5603/RPOR.a2023.0041. eCollection 2023.
10
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.尤因肉瘤分子生物标志物优先级的国际工作组共识报告。
NPJ Precis Oncol. 2022 Sep 17;6(1):65. doi: 10.1038/s41698-022-00307-2.